| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |